Table 1. Subjects' characteristics according to hemodialysis duration.
Characteristics | D1 (n = 58) | D2 (n = 45) | D3 (n = 42) | p value | |
---|---|---|---|---|---|
Age, yr | 61.5 ± 11.9 | 62.1 ± 10.7 | 63.0 ± 9.4 | 0.780 | |
Sex | 0.664 | ||||
Male | 26 (42.1) | 22 (48.0) | 20 (45.5) | ||
Female | 32 (57.9) | 23 (52.0) | 22 (54.5) | ||
BMI | 0.003 | ||||
< 18.5 | 3 (5.2) | 8 (17.8) | 12 (28.6) | ||
18.5–22.9 | 34 (58.6) | 21 (46.7) | 24 (57.1) | ||
> 22.9 | 21 (36.2) | 16 (35.6) | 6 (14.3) | ||
eGFR, mL/min/1.73 m2 | 18.4 ± 10.2 | 16.1 ± 8.3 | 15.8 ± 9.6 | 0.328 | |
CCI | 3.4 ± 1.4 | 4.1 ± 1.7 | 4.6 ± 2.2 | 0.002* | |
SGA | 0.107 | ||||
Severe PEW | 4 (6.9) | 5 (11.1) | 6 (14.3) | ||
Moderate to mild PEW | 14 (24.2) | 17 (37.8) | 14 (33.3) | ||
Well-nourished | 40 (68.9) | 23 (51.1) | 22 (52.4) |
Data represented as mean ± standard deviation and number (%).
The p value by ANOVA test (continuous variables) or χ2 test (categorical variables).
D1, less 1 year; D2, 1–5 years; D3, above 5 years; BMI, body mass index; eGFR, estimated glomerular filtration rate; CCI, Charlson comorbidity index; SGA, subjective global assessment; PEW, protein-energy wasting; ANOVA, analysis of variance.
*There exists the significant difference between D1 and D3 groups.